Agenda

PharmaSupply, GIRP’s flagship conference on the pharmaceutical supply chain, will bring together EU regulators, policymakers, industry leaders, and healthcare stakeholders at its 2026 edition to address the regulatory, operational, and technological changes reshaping Europe’s medicines supply chain.

PharmaSupply 2026 will provide a platform to understand, anticipate, and respond to the regulatory developments, structural challenges, and innovation opportunities facing the pharmaceutical supply chain in Europe.

DAY 1, NOVEMBER 4

WELCOME COFFEE & REGISTRATION 

8:30-9:00

WELCOME REMARKS
Katarina Gabrielson, CEO, Oriola & President, GIRP 

9:00-9:05

OPENING ADDRESS (VIDEO) – The Evolution of the European Regulatory Landscape: The GPL and What It Means for the Supply Chain
Olivér Várhelyi, European Commissioner for Health and Animal Welfare  

9:05-9:15

PRESENTATION – Supply Chain Review 2026: New Products, New Channels, New Opportunities

  • Simon Tottman, Vice President, Global Strategic Partners, IQVIA
  • Max Newton, Principal, Global Strategic Partners, IQVIA 

9:15-9:45

PANEL – Implementing the General Pharmaceutical Legislation: Perspectives from Across the Supply Chain
Moderator: Kasper Ernest, Director-General, GIRP 

  • Hugues Malonne, CEO, Federal Agency for Medicines and Healthcare Products
  • Mari Krass, CEO, Magnum AS  
  • Maja Leon Grzymkowska, Legal Officer, Medical Products: Quality, Safety, Innovation, DG SANTE
  • Ilaria Passarani, Secretary General, PGEU
  • Hugh Pullen, Vice President, Head of Public Affairs Region Europe, Novartis 

9:45-11:00

COFFEE BREAK

11:00-11:30

KEYNOTE – The New GDP Legislation: How Will European GDP Rules Evolve?
Emil Schwan, Scientific Specialist, European Medicines Agency & Chair of the
GDP Drafting Group 

11:30-11:45

PRESENTATION – Wholesalers’ Position on the New GDP Delegated Regulation
Laura Ribeiro, Head of Quality and Regulatory Affairs, OCP Portugal

11:45-12:00

PANEL – The Future of GDP: Inspectors’ View
Moderator: Peter Brown, Expert GDP Inspector, MHRA (UK Medicines Agency) 

  • Emil Schwan, Scientific Specialist, European Medicines Agency & Chair of the
    GDP Drafting Group 
  • Manuel Ibarra, Head of Department, Pharmaceutical Inspection and
    Enforcement Department, AEMPS (Spanish Medicines Agency)
  • Simona-Raluca Manole, Director, GDP Inspection Service, General Directorate for Pharmaceutical Inspection, ANMDMR (Romanian Medicines Agency)
  • Karin Pöllitzer, GDP Inspector, Austrian Federal Office for Safety in Health Care (Austrian Medicines Agency)
  • Ave Lemmik, GDP Inspector, Ravimiamet (Estonian Medicines Agency)

12:00-13:00

LUNCH BREAK

13:00-14:00

PRESENTATION – How operational performance changes competitive power in pharmaceutical distribution and retail

  • TBC

14:00-14:15

PANEL – The Way Towards Digital Transformation: Enabling Data as Building Blocks
Moderator: Kasper Ernest, Director-General, GIRP 

  • Frederic Menardo, Regional Vice President, NNIT
  • Christophe Maes, Senior Chief Business Development & Audit Manager, The European Institute for Innovation through Health Data   
  • Pierre Chauvet, Director R&D Data Governance, Servier (TBC)
  • Katarina Gabrielson, CEO, Oriola

14:15-15:10

PRESENTATION – The Invisible Prescription: How automation creates time for patients 
Dieter Hochörtler, Director Sales & Systems Engineering Europe, KNAPP

15:10-15:25

COFFEE BREAK

15:25-15:55

CASE PRESENTATION – Medication Adherence Packaging
Hans Verstijnen, Chief Strategy Officer, Mosadex

15:55-16:10

PANEL – Medicine Adherence in Europe: Is the Framework Fit for Purpose?
Moderator: Kasper Ernest, Director-General, GIRP 

  • Patrick Van Ginneken, Director, Residential Care, Multipharma  
  • Hans Verstijnen, Chief Strategy Officer, Mosadex
  • Mark Roylance, Global Industry Leader – Patient-Specific Medication, BD Rowa 
  • Prof. Marie Schneider, Associate Professor, University of Geneva

16:10-17:00

CLOSING REMARKS
Kasper Ernest, Director-General, GIRP 

17:00

CONFERENCE DINNER at the Royal Museum of Art & History
Parc du Cinquantenaire, Brussels, Belgium

19:00-22:30

DAY 2, NOVEMBER 5

OPENING KEYNOTE – Shortages in Europe: Political Priority and Shared Responsibility
Monica Dias, Head of Supply and Availability of Medicines and Medical Devices, EMA 

9:00-9:25

PRESENTATION – Shortages Dynamics in Europe
Irena Toneva, Director, Supplier Services, IQVIA 

9:25-9:40

PANEL – Shortages: Monitoring, Dialogue and Practice
Moderator: Kasper Ernest, Director-General, GIRP 

  • Monica Dias, Head of Supply and Availability of Medicines and Medical Devices, EMA 
  • Domenico Di Giorgio, Head, Office for Medicine Shortages, Product Quality and Counteracting Pharmaceutical Crime, Italian Medicines Agency (AIFA)
  • Katarína Gatialová, Director, EU Government Affairs & Policy, Viatris 
  • Koen Straetmans, CEO Febelco Group

9:40-10:40

COFFEE BREAK

10:40-11:10

PRESENTATION – The Pharmaceutical Last Mile Goes Electric: Designing Tomorrow’s Vehicle Conversions for Sustainability, Cold Chain Integrity, and Climate Change
Luca Barboni, CEO, Car Fibreglass 

11:10-11:25

PANEL – Shaping Logistics to Future Needs: What’s New in the Pharmaceutical Supply Chain
Moderator: Kasper Ernest, Director-General, GIRP 

  • Thomas De Bie, CEO, CAPPI  
  • Jean-Gaetan Guillemaud, Corporate Vice President, Sustainability, Zueling Pharma (TBC)
  • Miguel Antoine, Head of Global Distribution, Sanofi 
  • Lutz Schütte, Head of Corporate Infrastructure, PHOENIX Group

11:25-12:25

CLOSING REMARKS
Kasper Ernest, Director-General, GIRP  

12:25

DOWNLOAD AGENDA